Formula 1: Age is not the issue, says returning Alonso

McLaren driver Fernando Alonso of Spain waves to spectators in the pit during the qualifying session at the Yas Marina racetrack in Abu Dhabi, United Arab Emirates, on Nov 24, 2018.

LONDON: Two-times Formula One world champion Fernando Alonso said age was not the issue after securing a comeback deal with Renault to race into his 40s.

The Spaniard turns 39 this month and, after two seasons out, will be returning next year with the team that took him to his titles in 2005 and 2006.

“In Formula One for many years the time watch (stopwatch) is the only thing that matters, not the age,” Alonso told reporters in a video news conference on Wednesday.

“I never had a race classification based on the passport, date of birth. Always on the time watch.”

Alonso will be the oldest driver next year if his former Ferrari team mate Kimi Raikkonen, already 40 and now with Alfa Romeo, decides to stop.

While 40-year-old racers were relatively common in the sport’s early days, they are a rarity in modern Formula One with an increasing emphasis on youth.

McLaren’s Lando Norris, third in Austria last weekend, was only one-year-old when Alonso started racing at now-defunct Minardi in 2001.

Alonso’s future team mate Esteban Ocon is 23 and said last week that the Spaniard’s success “gave me the love for the sport”.

Team principal Cyril Abiteboul recognised some would question Renault’s choice of a veteran over an emerging young talent.

“I can already expect that our decision … could be seen as a lack of interest or loyalty towards our project of the Renault Sport Academy. And it’s not,” he said.

Abiteboul said the COVID-19 pandemic that delayed the season had made it hard to evaluate China’s Guanyu Zhou and Denmark’s Christian Lundgaard, the leading academy candidates.

“We are very serious about the academy, very serious about those two people in particular,” added the Frenchman.

“I’m sure Fernando, like Esteban, has lots to bring to their development.”

Z24 News

Leave a Reply

Your email address will not be published.

Next Post

EU secures potential COVID-19 drugs from Roche, Germany's Merck

Wed Jul 8 , 2020
BRUSSELS: The European Commission has struck deals with drugmakers Roche and Merck KGaA to secure supplies of experimental treatments for COVID-19, a Commission source told Reuters on Wednesday (Jul 8). The deals cover Roche’s arthritis medicine RoActemra and Merck’s multiple sclerosis drug Rebif – both seen as potential treatments for […]


Social menu is not set. You need to create menu and assign it to Social Menu on Menu Settings.